Currently the owners of both Premier League side Chelsea and Ligue 1 outfit Strasbourg, BlueCo are reportedly on the verge of ...

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Joel Fishbein will join the firm’s Technology investment banking practice as a ...

Insmed's Brinsupri is the first DPP1 inhibitor approved by the FDA and the first treatment for bronchiectasis to reach the ...

Hiring on Wall Street hasn't returned and some banks are engaging in quiet layoffs even as the deals market stabilizes from ...

Xponential Fitness faced a difficult second quarter, with the market reacting negatively to both its flat revenue performance and updated financial outlook. Management attributed the muted results to ...

As much as Saturday's news served as the unofficial start to next season, it also had far-reaching implications for a Lakers team in a unique point in its franchise history as it awaits the $10 ...

Chicago-based Vivid Seats is enacting a 1-for-20 reverse stock split to avoid being delisted from Nasdaq as its stock price and cash reserves continue to sink.

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

The company also advised a consortium led by former Guggenheim Partners President Todd Boehly on its bid for Chelsea Football Club, Bloomberg News previously reported.

Discover key insights from EPAM Systems' Q2 2025 earnings call: double-digit growth, raised outlook, AI-driven transformation, and a seamless CEO transition.